AUC Score :
Short-term Tactic1 :
Dominant Strategy :
Time series to forecast n:
ML Model Testing : Modular Neural Network (Emotional Trigger/Responses Analysis)
Hypothesis Testing : Independent T-Test
Surveillance : Major exchange and OTC
1Short-term revised.
2Time series is updated based on short-term trends.
Key Points
IMNN stock is predicted to experience considerable volatility driven by its pipeline progress and clinical trial outcomes. A positive readout from ongoing studies related to its immunotherapy candidates could lead to significant upward price movement, attracting investor interest and potential partnerships. Conversely, adverse trial results or regulatory hurdles present a substantial risk, potentially triggering sharp declines. Furthermore, the company's financial runway and cash burn rate will remain a critical factor, with any perceived instability posing a downside risk, while successful capital raises or improved financial projections could bolster confidence and support the stock. The broader market sentiment towards biotech and speculative growth stocks will also influence IMNN's trajectory, with a risk of broad market downturns disproportionately impacting its valuation.About IMNN
This exclusive content is only available to premium users.
ML Model Testing
n:Time series to forecast
p:Price signals of IMNN stock
j:Nash equilibria (Neural Network)
k:Dominated move of IMNN stock holders
a:Best response for IMNN target price
For further technical information as per how our model work we invite you to visit the article below:
How do KappaSignal algorithms actually work?
IMNN Stock Forecast (Buy or Sell) Strategic Interaction Table
Strategic Interaction Table Legend:
X axis: *Likelihood% (The higher the percentage value, the more likely the event will occur.)
Y axis: *Potential Impact% (The higher the percentage value, the more likely the price will deviate.)
Z axis (Grey to Black): *Technical Analysis%
| Rating | Short-Term | Long-Term Senior |
|---|---|---|
| Outlook | B1 | B2 |
| Income Statement | Baa2 | C |
| Balance Sheet | Caa2 | Baa2 |
| Leverage Ratios | Caa2 | C |
| Cash Flow | B2 | C |
| Rates of Return and Profitability | Baa2 | Ba2 |
*Financial analysis is the process of evaluating a company's financial performance and position by neural network. It involves reviewing the company's financial statements, including the balance sheet, income statement, and cash flow statement, as well as other financial reports and documents.
How does neural network examine financial reports and understand financial state of the company?
References
- Thompson WR. 1933. On the likelihood that one unknown probability exceeds another in view of the evidence of two samples. Biometrika 25:285–94
- Banerjee, A., J. J. Dolado, J. W. Galbraith, D. F. Hendry (1993), Co-integration, Error-correction, and the Econometric Analysis of Non-stationary Data. Oxford: Oxford University Press.
- Burgess, D. F. (1975), "Duality theory and pitfalls in the specification of technologies," Journal of Econometrics, 3, 105–121.
- Andrews, D. W. K. W. Ploberger (1994), "Optimal tests when a nuisance parameter is present only under the alternative," Econometrica, 62, 1383–1414.
- Burgess, D. F. (1975), "Duality theory and pitfalls in the specification of technologies," Journal of Econometrics, 3, 105–121.
- Mikolov T, Yih W, Zweig G. 2013c. Linguistic regularities in continuous space word representations. In Pro- ceedings of the 2013 Conference of the North American Chapter of the Association for Computational Linguistics: Human Language Technologies, pp. 746–51. New York: Assoc. Comput. Linguist.
- Dudik M, Langford J, Li L. 2011. Doubly robust policy evaluation and learning. In Proceedings of the 28th International Conference on Machine Learning, pp. 1097–104. La Jolla, CA: Int. Mach. Learn. Soc.